Your browser doesn't support javascript.
loading
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer.
Nahm, Christopher B; Turchini, John; Sahni, Sumit; Moon, Elizabeth; Itchins, Malinda; Arena, Jennifer; Chou, Angela; Colvin, Emily K; Howell, Viive M; Pavlakis, Nick; Clarke, Stephen; Samra, Jaswinder S; Gill, Anthony J; Mittal, Anubhav.
Affiliation
  • Nahm CB; The University of Sydney, Northern Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
  • Turchini J; Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital, St. Leonards, NSW 2565, Australia.
  • Sahni S; Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Sydney, NSW 2565, Australia.
  • Moon E; Australian Pancreatic Centre, Sydney, NSW 2565, Australia.
  • Itchins M; The University of Sydney, Westmead Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
  • Arena J; Surgical Innovations Unit, Westmead Hospital, Hawkesbury Road, Westmead NSW 2145, Australia.
  • Chou A; The University of Sydney, Northern Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
  • Colvin EK; Cancer Diagnosis and Pathology Group, Kolling Institute, Sydney, NSW 2565, Australia.
  • Howell VM; The University of Sydney, Northern Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
  • Pavlakis N; Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Sydney, NSW 2565, Australia.
  • Clarke S; Australian Pancreatic Centre, Sydney, NSW 2565, Australia.
  • Samra JS; The University of Sydney, Northern Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
  • Gill AJ; Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Sydney, NSW 2565, Australia.
  • Mittal A; The University of Sydney, Northern Clinical School, Faculty of Medicine and Health Sciences, Sydney, NSW 2565, Australia.
Cancers (Basel) ; 14(15)2022 Jul 25.
Article in En | MEDLINE | ID: mdl-35892879

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Australia